Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RO 15-4513 and its interaction with ethanol.

R G Lister1, D J Nutt

  • 1Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892.

Advances in Alcohol & Substance Abuse
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human brain changes after first psilocybin use.

Nature communications·2026
Same author

Serotonergic psychedelics for depression: A comprehensive overview.

International review of neurobiology·2025
Same author

Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study.

Archives of suicide research : official journal of the International Academy for Suicide Research·2024
Same author

Psilocybin and Other Classic Psychedelics in Depression.

Current topics in behavioral neurosciences·2023
Same author

Canalization and plasticity in psychopathology.

Neuropharmacology·2022
Same author

Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.

Psychopharmacology·2021

RO 15-4513, a potential alcohol-antagonist, exhibits proconvulsant and exploratory behavior-reducing effects in mice. These intrinsic actions, similar to benzodiazepine receptor partial inverse agonists, suggest caution regarding its use in humans.

Area of Science:

  • Neuropharmacology
  • Behavioral Neuroscience

Background:

  • Recent claims suggest RO 15-4513 selectively antagonizes ethanol's behavioral effects.
  • Understanding the intrinsic properties of RO 15-4513 is crucial for evaluating its therapeutic potential.

Purpose of the Study:

  • To investigate the intrinsic behavioral effects of RO 15-4513 in mice.
  • To determine if RO 15-4513's intrinsic actions explain its alcohol-antagonizing properties.

Main Methods:

  • Administration of RO 15-4513 to mice.
  • Observation and measurement of proconvulsant activity.
  • Assessment of exploratory behavior.
  • Evaluation of RO 15-4513's effects on ethanol, barbiturate, and benzodiazepine-induced behaviors.

Main Results:

Related Experiment Videos

  • RO 15-4513 demonstrated proconvulsant effects in mice.
  • Exploratory behavior was reduced by RO 15-4513.
  • The compound partially reversed behavioral effects of ethanol and a barbiturate.
  • Complete reversal of benzodiazepine behavioral effects was observed.

Conclusions:

  • RO 15-4513 possesses intrinsic proconvulsant and behavior-reducing properties.
  • These intrinsic actions align with those of a benzodiazepine receptor partial inverse agonist.
  • The findings raise concerns about the safety and efficacy of RO 15-4513 in humans for alcohol antagonism.